These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 15875510)
1. The role of the implantable atrial cardioverter-defibrillator. Santini M Ital Heart J; 2005 Mar; 6(3):206-9. PubMed ID: 15875510 [TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation: the role of atrial defibrillation. Santini M; Ricci R J Interv Card Electrophysiol; 2003 Oct; 9(2):229-33. PubMed ID: 14574036 [TBL] [Abstract][Full Text] [Related]
3. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study. Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005 [TBL] [Abstract][Full Text] [Related]
4. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. Goldberger Z; Elbel B; McPherson CA; Paltiel AD; Lampert R J Am Coll Cardiol; 2005 Sep; 46(5):850-7. PubMed ID: 16139136 [TBL] [Abstract][Full Text] [Related]
5. Long-term care of the patient with the atrial defibrillator. Mitchell AR; Spurrell PA; Boodhoo LE; Sulke N Am Heart J; 2004 Feb; 147(2):210-7. PubMed ID: 14760315 [TBL] [Abstract][Full Text] [Related]
6. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314 [TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation in the new millennium--the role of pacemaker and defibrillator therapy. Mitchell AR Med Sci Monit; 2002 Oct; 8(10):RA233-9. PubMed ID: 12388933 [TBL] [Abstract][Full Text] [Related]
8. The Food and Drug Administration and atrial defibrillation devices. Chen L; Keane AT; Every NR Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410 [TBL] [Abstract][Full Text] [Related]
9. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Ricci RP; Quesada A; Almendral J; Arribas F; Wolpert C; Adragao P; Zoni-Berisso M; Navarro X; DeSanto T; Grammatico A; Santini M; Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341 [TBL] [Abstract][Full Text] [Related]
10. Potential role of 'hybrid therapy' for atrial fibrillation. Lesh MD; Kalman JM; Roithinger FX; Karch MR Semin Interv Cardiol; 1997 Dec; 2(4):267-71. PubMed ID: 9704361 [TBL] [Abstract][Full Text] [Related]
11. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026 [TBL] [Abstract][Full Text] [Related]
12. Quality of life after use of the patient activated atrial defibrillator. Spurrell P; Mitchell A; Kamalvand K; Sulke N Int J Clin Pract; 2003; 57(1):30-4. PubMed ID: 12587939 [TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation in patients with implantable defibrillators. Sakhuja R; Shah AJ; Keebler M; Thakur RK Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771 [TBL] [Abstract][Full Text] [Related]
14. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL; Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858 [TBL] [Abstract][Full Text] [Related]
15. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator. Schernthaner C; Pichler M; Strohmer B Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140 [TBL] [Abstract][Full Text] [Related]
16. Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation. Mittal S; Stein K; Gilliam FR; Kraus SM; Meyer TE; Christman SA Am J Cardiol; 2008 Aug; 102(4):450-3. PubMed ID: 18678304 [TBL] [Abstract][Full Text] [Related]
17. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Manegold JC; Israel CW; Ehrlich JR; Duray G; Pajitnev D; Wegener FT; Hohnloser SH Eur Heart J; 2007 Jul; 28(14):1731-8. PubMed ID: 17569681 [TBL] [Abstract][Full Text] [Related]
18. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication. Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251 [TBL] [Abstract][Full Text] [Related]